HealthEquity, Inc. (HQY) Earnings History
Annual and quarterly earnings data from 2013 to 2026
Loading earnings history...
HQY EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
HQY Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2026 | 69.5% | 24.6% | 16.4% |
| 2025 | 57.7% | 19.2% | 8.1% |
| 2024 | 53.0% | 12.8% | 5.6% |
| 2023 | 45.9% | 4.4% | -3.0% |
| 2022 | 45.1% | 5.4% | -5.9% |
Download Data
Export HQY earnings history in CSV or JSON format
Free sign-in required to download data
HealthEquity, Inc. (HQY) Earnings Overview
As of May 8, 2026, HealthEquity, Inc. (HQY) reported trailing twelve-month net income of $215M, reflecting +125.7% year-over-year growth. The company earned $2.46 per diluted share over the past four quarters, with a net profit margin of 16.4%.
Looking at the long-term picture, HQY's 5-year EPS compound annual growth rate (CAGR) stands at +83.0%, indicating exceptional earnings growth. The company achieved its highest annual net income of $215M in fiscal 2026, representing a new all-time high.
HealthEquity, Inc. maintains industry-leading profitability with a gross margin of 69.5%, operating margin of 24.6%, and net margin of 16.4%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including WEX ($310M net income, 11.4% margin), BEN ($812M net income, 6.0% margin), INVA ($504M net income, 63.8% margin), HQY has outperformed on profitability metrics. Compare HQY vs WEX →
HQY Earnings vs Peers
Earnings metrics vs comparable public companies
HQY Historical Earnings Data (2013–2026)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | $215M | +122.5% | $322M | $2.46 | 16.4% | 24.6% |
| 2025 | $97M | +73.6% | $230M | $1.09 | 8.1% | 19.2% |
| 2024 | $56M | +313.1% | $128M | $0.64 | 5.6% | 12.8% |
| 2023 | -$26M | +41.0% | $38M | $-0.31 | -3.0% | 4.4% |
| 2022 | -$44M | -601.3% | $41M | $-0.53 | -5.9% | 5.4% |
| 2021 | $9M | -77.7% | $80M | $0.12 | 1.2% | 10.9% |
| 2020 | $40M | -46.3% | $109M | $0.58 | 7.5% | 20.5% |
| 2019 | $74M | +56.0% | $78M | $1.17 | 25.7% | 27.0% |
| 2018 | $47M | +79.6% | $54M | $0.77 | 20.6% | 23.7% |
| 2017 | $26M | +58.8% | $41M | $0.44 | 14.8% | 23.1% |
See HQY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HQY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HQY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHQY — Frequently Asked Questions
Quick answers to the most common questions about buying HQY stock.
Is HQY growing earnings?
HQY EPS is $2.46, with earnings growth accelerating to +125.7%. This exceeds the 5-year CAGR of +83.0%. TTM net income reached $215M.
What are HQY's profit margins?
HealthEquity, Inc. net margin is +16.4%, with operating margin at +24.6%. Above-average margins indicate pricing power.
How consistent are HQY's earnings?
HQY earnings data spans 2013-2026. The accelerating earnings trend is +125.7% YoY. Historical data enables comparison across business cycles.